About Cutanea Life Sciences
Cutanea Life Sciences is a company based in Wayne (United States) founded in 2005 was acquired by Biofrontera in March 2019. Cutanea Life Sciences has raised $900 thousand across 3 funding rounds from investors including Biofrontera. Cutanea Life Sciences operates in a competitive market with competitors including Incyte, LEO Pharma, Formation Bio, Arcutis and DermBiont, among others.
- Headquarter Wayne, United States
- SectorsHealthcare
- Phone•••• ••••
- Website cutanea.com
- Social LinkedIn X Facebook
- Acquired by Biofrontera (Mar 2019)
- Total Equity Funding$900K (USD)
in 3 rounds
- Latest Funding Round$450K (USD), Seed
Sep 2011
- Investors
- Acquired byBiofrontera
(Mar 2019)
Funding Insights of Cutanea Life Sciences
Cutanea Life Sciences has successfully raised a total of $900K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $450 thousand completed in September 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $900,000
- Total Rounds 3
- Last Round Seed — $450,000
All 3 funding rounds of Cutanea Life Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2011 | $450,000 | Seed | – | – | – |
| Jul 2011 | – | Debt – Conventional | – | – | – |
| Jul 2011 | $450,000 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Cutanea Life Sciences
Cutanea Life Sciences has secured backing from 1 investor. Prominent investors backing the company include Biofrontera.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Solutions for dermatological therapeutics and consumer products are provided. | 1997 | biofrontera.com | Leverkusen, Germany |
Investor details for Cutanea Life Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cutanea Life Sciences
1 people are tracked at Cutanea Life Sciences (1 in leadership).
| Name | Role | Group |
|---|---|---|
Robert Bitterman | CEO | Leadership |
Complete people profiles for Cutanea Life Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cutanea Life Sciences
4 dated milestones of Cutanea Life Sciences across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Cutanea Life Sciences is founded.
- Funding First funding round.
- Funding Latest funding round, Seed, of $450K.
- Exit Acquired by Biofrontera.
Competitors of Cutanea Life Sciences
Cutanea Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Incyte, LEO Pharma, Formation Bio, Arcutis and DermBiont, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| incyte.com | 1991 | Wilmington, United States | – | 1,387 | Small molecules are developed for cancer and skin disease treatments. | |
| leo-pharma.com | 1908 | Copenhagen, Denmark | $560.38M | 142 | Developer of drugs for treating dermatology diseases | |
| formation.bio | 2016 | New York, United States | $608M | – | AI-powered drug discovery platform for various diseases | |
| arcutis.com | 2016 | Westlake Village, United States | $94.5M | 296 | Immunotherapeutic solutions for dermatological conditions are developed. | |
| dermbiont.com | 2015 | Melrose, United States | $78.91M | 14 | Microbial therapeutics for skin diseases are developed. | |
| novan.com | 2006 | Morrisville, United States | $164.84M | 89 | Nitric oxide-based therapeutics for dermatology disorders are developed. | |
| evommune.com | 2020 | Sacramento, United States | $275.5M | – | Developer of therapeutic options for chronic inflammatory disorders | |
| edesabiotech.com | 2015 | Toronto, Canada | – | 49 | Topical therapeutics for dermatological and gastrointestinal diseases are developed. | |
| azitrainc.com | 2014 | Farmington, United States | $37.4M | 17 | Microbiome-based therapeutics for skin conditions like eczema are developed. | |
| verrica.com | 2013 | West Chester, United States | $29.86M | 40 | Therapeutic solutions for skin diseases like molluscum contagiosum are developed. |
Detailed competitors of Cutanea Life Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cutanea Life Sciences
Complete news archive for Cutanea Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Cutanea Life Sciences
10 companies that operate in the same segment as Cutanea Life Sciences (Dermatology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Developer of drugs for treating dermatology diseases | 1908 | Copenhagen, Denmark | USD 560.38 M | – | – | |
Skincare, beauty, and wellness services provided by VLCC across multiple countries. | 1989 | Delhi, Delhi, India | – | – | – | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608 M | – | – | |
Immunotherapeutic solutions for dermatological conditions are developed. | 2016 | Westlake Village, California, United States | USD 94.5 M | USD 376.07 M | 342 | |
Targeted small molecules are developed for oncology treatments. | 2010 | Singapore, Singapore | USD 100 M | – | – | |
Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured. | 2014 | Pune, Maharashtra, India | USD 25.97 M | USD 18.15 M | 508 | |
Novel dermatologic therapies are developed for skin conditions. | 2012 | Malvern, Pennsylvania, United States | USD 82 M | USD 7.83 M | 64 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cutanea Life Sciences
Cutanea Life Sciences was founded in 2005 and raised its 1st funding round 6 years after it was founded.
Cutanea Life Sciences is headquartered in Wayne, United States.
Robert Bitterman is the current CEO of Cutanea Life Sciences.
Cutanea Life Sciences is a funded company, having raised a total of $900K across 3 funding rounds to date.
Cutanea Life Sciences was established in 2005 in Wayne, United States, within the biotechnology sector focused on dermatology. Therapeutics targeting skin conditions such as acne, psoriasis, rosacea, atopic dermatitis, and HPV-induced warts are developed. A soft tissue implant remains in preclinical stages. Aktipak, combining erythromycin and benzoyl peroxide in gel form, is prescribed for acne vulgaris treatment.
Cutanea Life Sciences's top competitors include LEO Pharma, Formation Bio and Arcutis.
Cutanea Life Sciences has 1 investor. Key investors include Biofrontera.
Yes. Cutanea Life Sciences was acquired by Biofrontera in March 2019.